UNSPSC 51201816: Impromidine

This classification denotes an anti-lipidemic agent with the molecular formula C14H23N7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 931L4X5WMM, chemically known as guanidine, n-(3-(1h-imidazol-4-yl)propyl)-n-(2-(((5-methyl-1h-imidazol-4-yl)methyl)thio)ethyl)- but generally known as impromidine, which bears US NIH Compound Identifier 41376. European Medicines Agency schedules Impromidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08159MIG.

UNSPSC 51201816 Impromidine is a Commodity code. The recent state and local activity under this code shows little relevant procurement — the single posted opportunity is a sole source notice by the Mississippi State Department of Health for Yellow Fever Vaccine from Sanofi Pasteur, Inc., which does not align with the code's nominal pharmaceutical scope. State and local health departments represent a potential customer class for pharmaceutical products, but the mismatch between the code designation and the actual commodity being procured signals either a cataloging error or minimal recent activity under this specific Commodity code.

The sole opportunity on record is the Mississippi State Department of Health's notice posted July 13, 2026, with an objection deadline of August 3, 2026 at 10:00 a.m. CST; this is a proposed sole source procurement, not a competitive RFP or IFB. The notice does not specify quantity, contract term, or estimated value. No other recent state or local opportunities under this code appear in the source, and no repeat issuing bodies or geographic concentration emerges from available records.